INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 98 filers reported holding INHIBRX INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $420,381 | -44.9% | 22,909 | -22.1% | 0.00% | -100.0% |
Q2 2023 | $763,302 | +98.4% | 29,403 | +44.2% | 0.00% | – |
Q1 2023 | $384,759 | -18.3% | 20,390 | +6.7% | 0.00% | -100.0% |
Q4 2022 | $471,018 | +31.6% | 19,116 | -4.1% | 0.00% | – |
Q3 2022 | $358,000 | +163.2% | 19,926 | +66.6% | 0.00% | – |
Q2 2022 | $136,000 | -56.8% | 11,960 | +65.7% | 0.00% | – |
Q4 2021 | $315,000 | – | 7,220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |